[email protected]

Author: Khyati Patel

E2B(R3) Deadline

Pharmacovigilance Services

E2B(R3) Deadline April 2026: Is Your ICSR Submission Process FDA-Ready?

April 2, 2026 No Comments

Annex 15 Revision

Pharma Audits

Annex 15 Revision: Key Impacts on Qualification and Validation for GDP Operators

March 31, 2026 No Comments

Pharmacovigilance

Pharmacovigilance Services

Navigating Dual MHRA/EMA Pharmacovigilance Obligations Post-Windsor Framework

March 26, 2026 No Comments

GMP Annex 22

Pharmacovigilance Services

EU GMP Annex 22 (Artificial Intelligence): What GMP-Regulated Manufacturers Must Do Before the Effective Date

March 24, 2026 No Comments

EU Pharma Package

Pharma Audits

EU Pharma Package 2026: What It Means for GMP/GDP Operators Now

March 19, 2026 No Comments

Pharmacovigilance Services

EudraVigilance Data Masking in ICSRs: Breaking Down the New GVP Module VI Addendum II

March 17, 2026 No Comments

Regulation, Use & Inspector Expectations

Risk-Based Audits

AI-Powered Signal Detection in 2026: Regulation, Use & Inspector Expectations

March 12, 2026 No Comments

Pharma Audits

Pharma Audits

Third‑Party PV Subcontractors in the Crosshairs: How to Audit‑Proof Your Vendor Agreements

March 10, 2026 No Comments

GVP Module Updated

GVP Audits

GVP Module IX Update in Q2 2026: What’s Changing and How to Prepare Now

March 5, 2026 No Comments

Pharmacovigilance Regulations

Pharmacovigilance Services

Signal Management Overhaul: How to Adapt Your SOPs After the Deletion of Article 21(2)

March 3, 2026 No Comments

Let’s build a GxP-compliant future together.

Have a project in mind?

Partner with us to elevate your quality systems, ensure compliance, and drive meaningful business transformation.

Built with passion and purpose. Helping you grow smarter, not harder.

QUICK LINKS

CONTACT US

[email protected]

Newsletter Signup

Subscribe to our newsletter for the latest insights

Copyright © 2026 Quality Vigilance Ltd | All Rights Reserved || Powered by Prabisha Consulting